WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: IMMUNOTHERAPY IN ONCOLOGY

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on IMMUNOTHERAPY IN ONCOLOGY

Mark Identification

Proof of use for IMMUNOTHERAPY IN ONCOLOGY

We do not have any records of a proof of use for IMMUNOTHERAPY IN ONCOLOGY at this moment.

Click here to add a proof of use for IMMUNOTHERAPY IN ONCOLOGY

Possible trademark infringements of IMMUNOTHERAPY IN ONCOLOGY

Basic Information about IMMUNOTHERAPY IN ONCOLOGY

Serial Number
97154897
Filing Date
03 Dec 2021
Mark Drawing Code
4

Classifications

Declare the trademark use of IMMUNOTHERAPY IN ONCOLOGY on the blockchain with WikiTrademarks.io.

First use of IMMUNOTHERAPY IN ONCOLOGY anywhere
IMMUNOTHERAPY IN ONCOLOGY was first used on 31 May 2011 for the primary classification of goods and services, international, 016 (Paper goods and printed matter)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
016
US Codes
002; 005; 022; 023; 029; 037; 038; 050

Who owns IMMUNOTHERAPY IN ONCOLOGY?

1. The Lynx Group, LLC Cranbury NJ

Correspondent

Brian L. Petrequin, Esq.
GREENBERG TRAURIG LLP
500 CAMPUS DRIVE, SUITE 400
FLORHAM PARK,NJ 07932

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on IMMUNOTHERAPY IN ONCOLOGY